Figure 1
Checklist for secondary prevention of established atherosclerotic cardiovascular disease (ASCVD). ACS: acute coronary syndrome; AMI: acute myocardial infarction; TIA: transient ischemic attack; PAD: peripheral artery disease; ABI: ankle brachial index; LDL-C: low-density lipoprotein cholesterol; PSCK9i: proprotein convertase subtilisin/kexin type 9 inhibitor; HbA1c: glycated hemoglobin; GLP-1RA: glucagon-like peptide-1 receptor agonist; eGFR: estimated glomerular filtration rate; DKA: diabetic ketoacidosis; SGLT-2i: sodium-glucose cotransporter-2 inhibitor; HF: heart failure; CKD: chronic kidney disease; MTC: medullary thyroid cancer; MEN-2: multiple endocrine neoplasm type 2.
Figure 2
A proposed comprehensive tool for enhanced guideline-directed management in the secondary prevention of atherosclerotic cardiovascular disease. EMR: electronic medical record.